
Beijing approves experimental Covid-19 vaccine for use in Chinese military
The vaccine, known as Ad5-nCoV, was jointly-developed by the Beijing Institute of Biotechnology — part of the Chinese government’s Academy of Military Medical Sciences — and vaccine company CanSino Biologics.
You must be logged in to post a comment.